## 3 Results and Discussion
### LC-MS Profile
\) & \(\begin{array}{  
\begin{table}
\begin{tabular}{c c c c c c c c} \hline \hline
**Proposed Compound** & \(\mathbf{t_{R}}\)b **} & \multirow{6}{*}{\(10.9\)} & \multirow{6}{*}{\(223\), \(387\)} & \multirow{6}{*}{\(479\)} & \(461\) (\(5\)) [M \(-\) H \(-\) H\({}_{2}\)O]\({}^{-}\) & & & \\  & & & & \(359\) (\(5\)) [M \(-\) H \(-\) & & & \\  & & & & \(C_{4}\)H\({}_{9}\)O\({}_{4}\)]\({}^{-}\) & & & & \\  & & & & \(317\) (\(100\)) [M \(-\) H \(-\) & & & \\  & & & & \(glucose\)]\({}^{-}\) & & & \\  & & & & \(301\) (\(50\)) [M \(-\) H \(-\) & & & \\  & & & & \(Oglucose\)]\({}^{-}\) & & & \\  & & & & \(151\) (\(1\)) \({}^{13}\)A\({}^{-}\) & & & & \\  & & & & \(135\) (\(4\)) \({}^{0.3}\)A\({}^{-}\) & & & & \\ \hline \multirow{6}{*}{Baialein 6-methyl ether 7-glucuronidee **} & \multirow{6}{*}{\(237\), \(368\)} & \multirow{6}{*}{\(459\)} & \(445\) (\(13\)) [M \(-\) H \(-\) CH\({}_{3}\)]\({}^{-}\) & & & \\  & & & & \(441\) (\(8\)) [M \(-\) H \(-\) H\({}_{2}\)O]\({}^{-}\) & & & \\  & & & & \(358\) (\(3\)) \({}^{13}\)A\({}^{-}\) & & & \\  & & & & \(342\) (\(1\)) \({}^{0.3}\)A\({}^{-}\) & & & \\  & & & & \(283\) (\(100\)) [M \(-\) H \(-\) & \(0.74\pm 0.01\) & \(0.15\pm 0.01\) & \(1.73\pm 0.02\) \\  & & & & \(267\) (\(45\)) [M \(-\) H \(-\) & & & \\  & & & & \(Oglucuron\)]\({}^{-}\) & & & \\  & & & & \(145\) (\(2\)) \({}^{0.4}\)B\({}^{-}\) & & & \\ \hline \multirow{6}{*}{Myricetin 3-xylosidee **} & \multirow{6}{*}{\(208\), \(353\)} & \multirow{6}{*}{\(449\)} & \(430\) (\(5\)) [M \(-\) H \(-\) H\({}_{2}\)O]\({}^{-}\) & & & \\  & & & & \(317\) (\(100\)) [M \(-\) H \(-\) & & & \\  & & & & \(xylose\)]\({}^{-}\) & & & \\  & & & & \(301\) (\(65\)) [M \(-\) H \(-\) & \(4.61\pm 0.01\) & \(4.17\pm 0.02\) & \(6.22\pm 0.08\) \\  & & & & \(Oxylose\)]\({}^{-}\) & & & \\  & & & & \(151\) (\(2\)) \({}^{13}\)A\({}^{-}\) & & & \\  & & & & \(135\) (\(1\)) \({}^{0.3}\)A\({}^{-}\) & & & \\ \hline \multirow{6}{*}{Myricitrin 3-rhamosidee **} & \multirow{6}{*}{\(208\), \(349\)} & \multirow{6}{*}{\(463\)} & \(445\) (\(5\)) [M \(-\) H \(-\) H\({}_{2}\)O]\({}^{-}\) & & & \\  & & & & \(317\) (\(100\)) [M \(-\) H \(-\) & & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\ \hline \multirow{6}{*}{Quercitrin d **} & \multirow{6}{*}{\(257\), \(351\), \(367\)} & \multirow{6}{*}{\(447\)} & \(429\) (\(25\)) [M \(-\) H \(-\) H\({}_{2}\)O]\({}^{-}\) & & & & \\  & & & & \(301\) (\(100\)) [M \(-\) H \(-\) & & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\ \hline \multirow{6}{*}{Baicalin e **} & \multirow{6}{*}{\(13.4\)**[ENDFOOTNOTE]**} & \multirow{6}{*}{\(199\), \(227\), \(267\), \(337\)} & \multirow{6}{*}{\(445\)} & \(343\) (\(2\)) [\({}^{13}\)A\({}^{-}\) & & & \\  & & & \(269\) (\(100\)) [M \(-\) H \(-\) & & & \\  & & & \(267\) (\(100\)) [M \(-\) H \(-\) & & & \\  & & & \(285\) (\(20\)) [M \(-\) H \(-\) & & & \\  & & & & \(\phantom{0}\) & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & \\  & & & & \(\phantom{0}\) & & \\ \hline \multirow{6}{*}{Myricetin d **} & \multirow{6}{*}{\(13.7\)**} & \multirow{6}{*}{\(230\), \(253\), \(304\), \(368\)} & \(317\) & \(299\) ((30)\) [M \(-\) H \(-\) CH\({}_{3}\)]\({}^{-}\) & & & & \\  & & & \(\phantom{0}\) & & \(\phantom{0}\) & \\  & & & \(\phantom{0}\) & & \(\phantom{0}\) & \\  & & & \(\phantom{0}\) & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & \\  & & & & \(\phantom{0}\) & & & \\ \hline \multirow{6}{*}{Myricetin d **} & \multirow{6}{*}{\(230\), \(253\), \(304\), \(368\)} & \(317\) & \(165\) (\(14\)) [\({}^{13}\)B\({}^{-}\) & & &The aerial parts of _L.